Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Derivatization Techniques in GC – V 2.0

Posted on By

Analytical Method Development: Derivatization Techniques in GC – V 2.0

SOP for Derivatization Techniques in Gas Chromatography for Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/087/2025
Supersedes SOP/AMD/087/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the standard procedures for implementing derivatization techniques in gas chromatography (GC) for the purpose of enhancing the analytical performance of non-volatile, polar, or thermally labile

compounds during method development.

2. Scope

This SOP is applicable to all GC method development and validation activities conducted in the Analytical Method Development (AMD) department involving pharmaceutical raw materials, intermediates, or drug products requiring chemical modification prior to analysis.

3. Responsibilities

  • Analytical Chemist: Performs derivatization, method development, and documentation of GC parameters.
  • Reviewer: Validates method optimization and evaluates specificity and repeatability.
  • QA Officer: Ensures compliance with safety, reagent handling, and recordkeeping.
  • Head – AMD: Approves the finalized method for analytical and regulatory use.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring derivatization methods are appropriate, justified, and validated as per ICH and compendial guidelines.

See also  Analytical Method Development: SOP for Microbial Load Method Development for Creams - V 2.0

5. Procedure

5.1 Introduction to Derivatization

  1. Derivatization involves chemical modification of analytes to improve:
    • Volatility
    • Thermal stability
    • Detector response (especially for FID or MS)
  2. Common functional groups targeted: hydroxyl, amine, carboxylic acid, carbonyl.
  3. Document compound functional groups in Annexure-1: Functional Group Mapping Sheet.

5.2 Selection of Derivatization Reagents

  1. Choose reagent based on analyte functional group:
    • Silylation: BSTFA, MSTFA for OH, COOH, NH2
    • Acylation: Acetic anhydride, PFPA for hydroxyl or amino groups
    • Alkylation: Diazomethane, iodomethane for COOH groups
  2. Ensure reagent compatibility with matrix and GC column.
  3. Record justification in Annexure-2: Reagent Selection Log.

5.3 Derivatization Procedure

  1. Silylation (e.g., using BSTFA):
    • Weigh 2–10 mg sample in reaction vial.
    • Add 100–200 µL BSTFA + 1% TMCS reagent.
    • Incubate at 60°C for 30 minutes in dry conditions.
  2. Acylation (e.g., with acetic anhydride):
    • Dissolve sample in pyridine.
    • Add equal volume of acetic anhydride and vortex.
    • Incubate at room temperature for 15–30 min.
  3. Alkylation (e.g., using diazomethane):
    • Use freshly prepared diazomethane in ethereal solution.
    • Add dropwise to sample in dried solvent (e.g., methanol).
    • React under fume hood for 10–20 min at RT.
  4. Filter and inject derivatized sample immediately.
  5. Log experimental conditions in Annexure-3: Derivatization Execution Log.
See also  Analytical Method Development: SOP for Conducting Inter-Laboratory Analytical Method Comparability - V 2.0

5.4 GC Method Development

  1. Select non-polar columns (e.g., DB-1, DB-5) for derivatized compounds.
  2. Optimize oven temperature ramp to prevent early elution or degradation.
  3. Validate injection port compatibility (split vs splitless).
  4. Run blank and derivatized sample for comparison.
  5. Document in Annexure-4: GC Method Development Worksheet.

5.5 Specificity and Linearity

  1. Ensure no interference from unreacted reagent or by-products.
  2. Run linearity with derivatized standards over 5 concentration levels.
  3. Acceptance Criteria:
    • R² ≥ 0.995
    • %RSD ≤ 2%
  4. Log data in Annexure-5: Linearity and Specificity Report.

5.6 Safety and Waste Disposal

  1. Use derivatizing agents in fume hood with appropriate PPE (gloves, goggles, lab coat).
  2. Label all reagents and derivatized vials with hazard warnings.
  3. Dispose of excess reagents and derivatized waste as per EHS guidelines.
  4. Record in Annexure-6: Reagent Safety and Disposal Log.

6. Abbreviations

  • GC: Gas Chromatography
  • BSTFA: N,O-Bis(trimethylsilyl)trifluoroacetamide
  • MSTFA: N-Methyl-N-(trimethylsilyl)trifluoroacetamide
  • FID: Flame Ionization Detector
  • SOP: Standard Operating Procedure

7. Documents

  1. Functional Group Mapping Sheet – Annexure-1
  2. Reagent Selection Log – Annexure-2
  3. Derivatization Execution Log – Annexure-3
  4. GC Method Development Worksheet – Annexure-4
  5. Linearity and Specificity Report – Annexure-5
  6. Reagent Safety and Disposal Log – Annexure-6
See also  Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <621> – Chromatography
  • USP General Chapter on Derivatization Techniques (if applicable)
  • Regulatory EHS Guidelines – Chemical Handling and Disposal

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Functional Group Mapping Sheet

Sample ID Functional Group Reactivity
API-101 Carboxylic acid Requires methylation

Annexure-2: Reagent Selection Log

Analyte Reagent Derivatization Type Justification
API-101 BSTFA Silylation Improves volatility and detection

Annexure-3: Derivatization Execution Log

Date Sample ID Reagent Incubation Temp Time Remarks
18/05/2025 API-101 BSTFA 60°C 30 min Clear solution

Annexure-4: GC Method Development Worksheet

Column Oven Program Injection Mode Split Ratio
DB-5 50–280°C @ 10°C/min Split 10:1

Annexure-5: Linearity and Specificity Report

Level (%) Peak Area % RSD Status
100% 124523 1.2% Pass

Annexure-6: Reagent Safety and Disposal Log

Reagent Hazard Class PPE Used Disposal Method
BSTFA Flammable, corrosive Gloves, goggles Organic solvent waste bin

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Annexures for safety and specificity added Regulatory and EHS alignment
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Handling Deviations During Manufacturing – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intradermal Injections – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version